Study of Adalimumab in Patients With Axial Spondyloarthritis
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Study ID
- NCT00939003
- Phase
- PHASE3
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Adalimumab — BIOLOGICAL40 mg every other week up to Week 12
- Placebo — BIOLOGICALPlacebo every other week up to Week 12
- Open-label Adalimumab — BIOLOGICAL40 mg every other week, Week 12 through Week 156
Study Details
This study will evaluate how well adalimumab works in the short and long term in patients with axial spondyloarthritis who are not diagnosed as having either ankylosing spondylitis or psoriatic arthritis.
Key Dates
- Start date
- Jul 31, 2009
- Status verified
- Sep 2014
- Primary completion
- Feb 28, 2011
- Completion
- Aug 31, 2013
Study Design
- Enrollment
- 192 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Adalimumab
- Placebo Comparator: Placebo
- Experimental: Open-label Adalimumab
Primary Outcome Measure
Number of Participants Achieving an Assessment of Spondyloarthritis International Society (ASAS) 40 Response [ Time Frame: Baseline and Week 12 ]
Locations (9)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Site Reference ID/Investigator# 21250 | Birmingham | Alabama | 35205 | - |
| Site Reference ID/Investigator# 21249 | Colorado Springs | Colorado | 80910 | - |
| Site Reference ID/Investigator# 21245 | Denver | Colorado | 80230 | - |
| Site Reference ID/Investigator# 21246 | Wheaton | Maryland | 20902 | - |
| Site Reference ID/Investigator# 26582 | Duncansville | Pennsylvania | 16635 | - |
| Site Reference ID/Investigator# 21241 | Wyomissing | Pennsylvania | 19610 | - |
| Site Reference ID/Investigator# 21243 | Dallas | Texas | 75231 | - |
| Site Reference ID/Investigator# 21248 | Houston | Texas | 77030 | - |
| Site Reference ID/Investigator# 21247 | Seattle | Washington | 98122 | - |
Find similar trials in Birmingham, AL
By research site
Site Reference ID/Investigator# 21250· Birmingham, ALSite Reference ID/Investigator# 21249· Colorado Springs, COSite Reference ID/Investigator# 21245· Denver, COSite Reference ID/Investigator# 21246· Wheaton, MDSite Reference ID/Investigator# 26582· Duncansville, PASite Reference ID/Investigator# 21241· Wyomissing, PA
Related Studies
- A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in AdultsPHASE1 · Recruiting · UCB Biopharma SRL · Peoria, Arizona
- Physical Activity Through Health Technology in Axial SpondyloarthritisRecruiting · University of Washington · Seattle, Washington
- A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)PHASE1 · Recruiting · UCB Biopharma SRL · Santa Monica, California